Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant H5N1 influenza HA vaccine booster

recombinant influenza HA vaccine (H5N1) booster · UMN Pharma Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant H5N1 influenza HA vaccine booster, covering 2011-02-08 to 2011-02-08. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety Study of a Booster Vaccination With a Recombinant H5N1 Influenza HA Vaccine in Primed Adults [Phase 2]

See pricing